Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dopamine release is the process by which dopamine, a key neurotransmitter, is secreted from neurons into the synaptic cleft or extracellular space. This event enables dopamine to interact with its receptors on target cells, influencing a wide range of physiological functions including motor control, motivation, reward processing, and learning. Dysregulation of dopamine release is implicated in disorders such as Parkinson’s disease, schizophrenia, drug addiction, and ADHD.
Dopamine release is modulated by drugs that affect dopamine synthesis, storage, release, reuptake, or degradation. Agonists stimulate dopamine receptors, while antagonists block them. Reuptake inhibitors increase dopamine levels in the synapse by preventing its removal. MAOIs prevent dopamine breakdown, increasing its availability.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine Release.